These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 20224314

  • 1. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
    Williams DE, Prieto MC, Mullins JJ, Navar LG, Mitchell KD.
    Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats.
    Howard CG, Mullins JJ, Mitchell KD.
    Am J Med Sci; 2010 Jun; 339(6):543-8. PubMed ID: 20375689
    [Abstract] [Full Text] [Related]

  • 4. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
    Howard LL, Patterson ME, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F810-5. PubMed ID: 15585671
    [Abstract] [Full Text] [Related]

  • 5. Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Milani CJ, Kobori H, Mullins JJ, Mitchell KD.
    Am J Med Sci; 2010 Nov; 340(5):389-94. PubMed ID: 20724906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
    Howard CG, Mullins JJ, Mitchell KD.
    Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
    [Abstract] [Full Text] [Related]

  • 8. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Mitchell KD, Mullins JJ.
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
    [Abstract] [Full Text] [Related]

  • 9. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
    Erbanová M, Thumová M, Husková Z, Vanecková I, Vanourková Z, Mullins JJ, Kramer HJ, Bürgelová M, Rakusan D, Cervenka L.
    J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
    [Abstract] [Full Text] [Related]

  • 10. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
    Sedláková L, Kikerlová S, Husková Z, Červenková L, Chábová VČ, Zicha J, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Krátký V, Červenka L, Kopkan L.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30054426
    [Abstract] [Full Text] [Related]

  • 11. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z, Kopkan L, Červenková L, Doleželová Š, Vaňourková Z, Škaroupková P, Nishiyama A, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Červenka L.
    Clin Exp Pharmacol Physiol; 2016 Apr 31; 43(4):438-49. PubMed ID: 26833491
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
    Patterson ME, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2008 Jan 31; 294(1):F205-11. PubMed ID: 17977909
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Opay AL, Mouton CR, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2006 Sep 31; 291(3):F612-8. PubMed ID: 16622181
    [Abstract] [Full Text] [Related]

  • 15. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.
    Vanourková Z, Kramer HJ, Husková Z, Vanecková I, Opocenský M, Chábová VC, Tesar V, Skaroupková P, Thumová M, Dohnalová M, Mullins JJ, Cervenka L.
    J Hypertens; 2006 Dec 31; 24(12):2465-72. PubMed ID: 17082731
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
    Ortiz RM, Graciano ML, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2007 Nov 31; 293(5):F1584-91. PubMed ID: 17715265
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.